8-K/A
Current Report
Cocrystal Pharma, Inc. Filed Acc 0001521536-12-000060
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading q1100336_8ka-biozone.htm…